Clinical Trial Update: Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial combining radiotherapy, cetuximab, and TNFerade Biologic for elderly or frail patients with head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• TNFerade Biologic (TNFerade)

Snippet

Sponsor: GenVec | Conditions: Head and Neck Cancer, Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED